● Recruiting

Blood Biomarkers for Alzheimer Disease and Neuro-injury to Estimate the Association With Cognitive/Functional Decline and Mortality in a Real-world Population of GERiatric Hospitalized Patients (BAD-GER)

Condition: Alzheimer Disease · Old Age; Dementia · Sponsor: Istituto Nazionale di Ricovero e Cura per Anziani

PhaseN/A

Planned participants400

Who can joinAll sexes, 65 Years to no upper limit

Healthy volunteersNo

About this study

The BAD-GER study is a multicenter, prospective, three-arm observational study serving to validate a prognostic biomarker algorithm for mortality and hospital readmission; this algorithm will be developed through the retrospective analysis of Alzheimer's Disease and neurodegeneration biomarkers in an already available discovery cohort of 700 previously hospitalized geriatric patients.

This description comes directly from the study's public registry record.

Talk to the study team

Anna Rita Bonfigli · +390718003719 · a.bonfigli@inrca.it

Always discuss trial participation with your own doctor first.

Locations (3)

IRCCS INRCA Hospital	Ancona, Italy	Recruiting
IRCCS INRCA Hospital	Fermo, Italy	Recruiting
Policlinico Universitario	Messina, Italy	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07435467